China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

符号: 000999.SZ

SHZ

60.44

CNY

今天的市场价格

  • 19.3562

    市盈率

  • 0.6713

    PEG比率

  • 59.16B

    MRK市值

  • 0.02%

    DIV收益率

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999-SZ) 财务报表

在图表中,您可以看到 的动态默认数字 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ). 的默认数据。公司收入显示 7144.644 M 的平均值,即 0.131 % 增长率。整个期间的平均毛利润为 4165.555 M,即 0.128 %. 平均毛利率为 0.556 %. 公司去年的净收入增长率为 0.165 %,等于 0.118 % % 整个公司历史的平均增长率.,

资产负债表

深入分析 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 的财务轨迹,我们可以看到其平均资产增长率。有趣的是,这一增长率为 ,反映了公司的高点和低点。与季度相比,这一数字调整为0. 回顾过去一年,总资产变化为 0.480. 在流动资产领域,000999.SZ 的报告货币为22522.003. 这些资产中的很大一部分,即 8226.787 是现金和短期投资。与去年的数据相比,该部分的变化率为1.612%. 公司的长期投资虽然不是其重点,但以报告货币计算的724.938(如果有的话)为724.938。这表明与上一报告期相比,-75.410% 的差异反映了公司的战略转变. 公司的债务概况显示,以报告货币计算的长期债务总额为 1802.932. 这一数字表明,9.079% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 18967.142. 这方面的年同比变化率为 0.115%. 深入了解公司财务信息后,会发现更多细节。应收账款净额的估值为8581.24,存货估值为 5112.5,商誉估值为 5123.93(如有. 无形资产总额(如果有)按 4078.25 估值.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997

balance-sheet.row.cash-and-short-term-investments

31131.858226.83149.74283.9
4022.4
3045.8
2476.4
1708.4
910.8
973.2
1140
1362
1345.9
2022.6
1731.2
1273.2
718.1
824.6
546.7
363.9
643.6
2246.3
1772.3
1313.9
2294.2
1168.5
76.6
252.6

balance-sheet.row.short-term-investments

4438.41873.3-2647.11218.8
200.2
-106.9
-84.8
-77.6
-68.7
-70.2
-61.3
0
-54.3
-31.1
0
0
0
0
0
0
0
0
5
0
0
0
0
0

balance-sheet.row.net-receivables

35661.868581.26071.35659.4
5054.1
5761.2
4512.3
4003.5
2859.3
2461.8
2010.6
2190.9
1944.5
1439.8
1283.2
1345.2
1374.2
5062.1
4743
4777.7
8549.3
6614
2903.8
3821
121.2
414.9
43.7
21.3

balance-sheet.row.inventory

19561.085112.52498.92308.5
1761.6
1432.4
1533.4
1105.2
904.8
910.6
858.3
999.9
823.7
683.5
490.4
418.4
484.3
601.7
407.3
429.7
322.8
372.3
446.1
470.9
520.4
302.8
278.5
283.2

balance-sheet.row.other-current-assets

2087.77601.5268.6226.6
87.1
53.3
54.4
26.6
407.6
867.8
1114.4
622.7
23.7
0.4
0.2
0.4
10
10.1
5.7
5.3
-3940.4
-2807.3
0.1
0.1
1867.9
1256.2
1042.9
669.9

balance-sheet.row.total-current-assets

88442.552252211988.512478.4
10925.2
10292.8
8576.5
6843.6
5082.5
5213.3
5123.3
5175.5
4137.9
4146.3
3505
3037.2
2586.5
6498.5
5702.6
5576.6
5575.3
6425.4
5122.3
5605.9
4803.7
3142.3
1441.6
1227

balance-sheet.row.property-plant-equipment-net

26485.46802.648234237.8
3770.7
3611.7
3526.1
3555.8
3272.3
3076.7
2809
2771.4
2436.6
1977.7
1340.2
1352.3
1256.6
1082.1
996
1009.6
1070.9
1028.4
913.4
776.2
799.3
308.2
216.3
206.2

balance-sheet.row.goodwill

20610.445123.93994.94060.4
4104.6
3353.7
3543.9
3549.8
3142.2
1730.7
707.3
581.9
307
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

16356.234078.32749.92646.6
2586.9
2097.4
2038.9
1965.1
1837.1
1763.5
1611.1
1554.1
1461.4
1319
1161.8
1148.8
1104.6
66.1
55
47.8
52
81.3
83.3
74.4
98.7
35.1
24.8
16.2

balance-sheet.row.goodwill-and-intangible-assets

36966.689202.26744.76707
6691.5
5451.1
5582.8
5514.9
4979.3
3494.2
2318.4
2136
1768.4
1319
1161.8
1148.8
1104.6
66.1
55
47.8
52
81.3
83.3
74.4
98.7
35.1
24.8
16.2

balance-sheet.row.long-term-investments

2002.87724.92948.1-980.1
-23.8
148.8
132.3
91.1
82.6
92.9
256
0
74.1
50
0
0
0
0
0
0
0
0
660.2
0
0
0
0
0

balance-sheet.row.tax-assets

2492.53626.8324.5241.4
150.3
125.8
109.9
112.1
87
91.1
99.3
75.6
61.9
59.6
47.5
51.8
70.8
70.6
0
0
0
0
72.9
0
0
0
0
0

balance-sheet.row.other-non-current-assets

2569.73270293.91623.5
496.2
473.4
102.3
77.9
48.1
51
61.2
84
133.6
46.4
36.6
41.4
33
56
301
409.3
479.4
761.1
-1.9
142.5
188.1
93.9
24.1
18.5

balance-sheet.row.total-non-current-assets

70517.217626.515134.311829.6
11084.9
9810.7
9453.4
9351.8
8469.3
6805.9
5543.9
5067
4474.5
3452.7
2586.1
2594.2
2465
1274.9
1352
1466.7
1602.3
1870.9
1728
993.1
1086.1
437.3
265.2
240.9

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

158959.7540148.527122.824308
22010.1
20103.5
18029.9
16195.5
13551.7
12019.3
10667.2
10242.5
8612.4
7599
6091.2
5631.4
5051.5
7773.4
7054.6
7043.3
7177.6
8296.2
6850.2
6599.1
5889.9
3579.6
1706.8
1467.9

balance-sheet.row.account-payables

10661.52365.21795.11415.8
1117.6
1027.3
1041.5
1132.1
903.6
924.5
725.7
1033.7
721.3
804.5
606
629.7
713.6
490.9
468.2
540.2
831.5
684.4
790.2
331.1
460.1
403
413
326.4

balance-sheet.row.short-term-debt

6351.272019.9235.1110.7
30.8
30
35.2
530.1
20.1
0.7
36.9
37
79.1
61.3
43
12
95.5
3103.6
3233
3244.8
3388.9
4032.8
2732.7
2739.3
1824.8
245.7
321.5
361

balance-sheet.row.tax-payables

1709.78254.5518.1373.9
387.7
311.4
293.4
277.1
248.7
211.7
207.9
248.5
222.1
112.7
115.2
131.4
158.4
97
110.1
116.1
124.1
111.5
50
67
26.3
87.3
90.7
79.9

balance-sheet.row.long-term-debt-total

7337.291802.915696.7
101.4
10.2
10.2
0.2
499.9
499.7
508.5
501.1
26.3
4.3
2.9
39.5
14.6
15.6
24.7
35.2
60
76.1
21.2
192.3
162.9
17
10
4.9

Deferred Revenue Non Current

2242.3455.5423.2395.1
346.4
355.3
375.4
395.3
384.7
393.6
361
9.8
10.5
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

1527.48---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

14138.216911.75630.2234.5
152.1
22.3
4946.4
448.4
264.9
336.9
228.5
288.6
359.9
200.5
417.5
448.8
328.8
672.7
61.6
128.5
126.4
23.6
31.5
25.6
11.7
20.3
16.1
10.5

balance-sheet.row.total-non-current-liabilities

11689.152474.3916.7819.8
655.6
528.5
544.9
566.3
1043.4
1043.7
1000.6
865.6
346.7
112.8
54.7
69.9
14.6
15.6
45.4
63
68.1
85.5
28.1
193.7
171.3
36.7
16.1
7.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

494.4119.5105.888.7
148.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

61904.8415421.29589.48595.3
7951.1
7221.6
6861.4
6070.8
4830.4
4345.1
3671.7
3881.5
3036.3
2748.5
1627.4
1679.9
1638.8
4889.9
4509.4
4651
4889.8
5202.4
3948.3
3646.9
2909.6
926
959.7
897.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

3952.9988.2988.3978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
978.9
753
753
753
753
694.8
519.2

balance-sheet.row.retained-earnings

62863.0516047.313761.412131.5
10581.5
9871.8
8141.1
7154.4
6009.3
4958.3
4176.2
3599.5
2776.4
2063.3
1626
1149.3
694.9
251
-202.7
-365
-484.8
322.8
146.3
76.7
56.7
108.1
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

6444.97754.6673.1549.3
543.8
545.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

2509.2211771586.71622.9
1622.9
1167.9
1707.7
1705.2
1626.8
1634.4
1604.9
1570.4
1554.5
1502.8
1608.1
1558.1
1526.2
1499.9
1620.7
1618.8
1619.8
1607.6
1799.6
1774.2
1772.8
1714.8
0
0

balance-sheet.row.total-stockholders-equity

75770.1418967.117009.615282.5
13727.1
12563.8
10827.7
9838.5
8615
7571.7
6759.9
6148.8
5309.8
4545
4212.9
3686.3
3200
2729.8
2396.8
2232.7
2113.9
2909.3
2698.9
2603.9
2582.5
2575.9
694.8
519.2

balance-sheet.row.total-liabilities-and-stockholders-equity

158959.7540148.527122.824308
22010.1
20103.5
18029.9
16195.5
13551.7
12019.3
10667.2
10242.5
8612.4
7599
6091.2
5631.4
5051.5
7773.4
7054.6
7043.3
7177.6
8296.2
6850.2
6599.1
5889.9
3579.6
1706.8
1467.9

balance-sheet.row.minority-interest

20819.425294.7523.8430.2
331.9
318
340.8
286.2
106.3
102.5
235.6
212.2
266.3
305.6
250.8
265.2
212.6
153.6
148.3
159.6
174
184.5
203.1
348.3
397.7
77.7
52.3
51.5

balance-sheet.row.total-equity

96589.5624261.917533.415712.7
14059
12881.9
11168.5
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

158959.75---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

6441.272598.3301238.7
176.3
41.8
47.5
13.5
13.9
22.7
194.6
26.6
19.8
18.9
18.1
17.3
16.2
23.2
275.9
380.9
433.2
697.9
665.2
108.8
112.4
78.6
8.2
7.8

balance-sheet.row.total-debt

13908.273942.3391.1207.4
30.8
30
35.2
530.3
520
500.4
545.4
538
105.4
65.5
45.9
51.5
110.1
3119.2
3257.7
3280
3448.9
4108.9
2753.9
2931.6
1987.7
262.7
331.5
361

balance-sheet.row.net-debt

-12785.17-2411.2-2758.6-2857.7
-3791.4
-3015.8
-2441.1
-1178.1
-390.9
-472.8
-594.6
-824
-1240.6
-1957.1
-1685.3
-1221.7
-608
2294.6
2711
2916.1
2805.3
1862.6
986.6
1617.6
-306.6
-905.7
254.9
108.4

现金流量表

在 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 的财务状况中,自由现金流在过去一段时间内发生了显著变化,呈现出 0.637 的转变。该公司最近通过发行 0 扩大了股本,与上一年相比出现了-0.016 的差异. 有趣的是,公司的部分股票,特别是 0,是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时,以报告货币计算,公司的应付账款目前为 315.29. 公司的投资活动产生了现金使用净额,按报告货币计算达到-821735320.000. 与上一年相比, -0.669 发生了变化. 在同一时期,公司记录了 853.71, 957.78 和 -1741.8,这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000,同比差异为0.000. 此外,公司还将-988.35 用于向股东分红。与此同时,该公司还采取了其他财务措施,即 3180.15,这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起,全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

cash-flows.row.net-income

3065.732852.924972080.8
1617.5
2139.1
1474.9
1326.5
1207.8
1274.7
1072.1
1214.6
1081.1
815.1
859.1
761.6
541.1
284.1
166.6
116.8
-718.8
223
153.4
124.1
205.8
230.5

cash-flows.row.depreciation-and-amortization

54.35853.7522.7476.2
391.5
334.9
349.4
320.4
282.5
233.7
234.8
231.8
224.7
133.6
117.4
105.5
83.1
69
83.6
72.7
90.4
64.2
63.6
52.7
71.6
56.5

cash-flows.row.deferred-income-tax

-74.4-137.7-63.5-87
-21.1
-8.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

82.91-1724.563.587
21.1
8.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-332.32-17-216.9-946.9
72
47
42.6
-150.4
-137.8
-114.7
-147.7
-32
-164.6
-22.6
-42.2
-42.4
456.2
-21.6
-25.4
-518.1
-1084.8
-433.5
98.3
-145.7
-38.5
-304.9

cash-flows.row.account-receivables

633.69633.7-71.8-674.7
620.9
-820.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-966.01-966-59.7-664.9
-286.8
87
-436
-144.4
-9.6
-61.1
108.1
-130.1
-135.8
-157.3
-102.8
-54.3
135.8
-188.5
55.5
-101
29
57.2
53
-24.8
-48.7
-22.6

cash-flows.row.account-payables

0315.3-21.9458.4
-241.1
774.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

00-63.5-65.7
-21.1
5.7
478.6
-5.9
-128.1
-53.7
-255.7
98.1
-28.8
134.8
60.6
11.9
320.4
166.9
-80.9
-417.1
-1113.8
-490.8
45.4
-120.9
10.1
-282.3

cash-flows.row.other-non-cash-items

1989.62393203.5260.3
142.9
-549.1
44.4
63.9
39.6
-133.8
25.2
53
70.6
28.7
-86
30.3
35.9
273.8
200.7
351.4
993.5
174.4
180.8
122.3
28
138.6

cash-flows.row.net-cash-provided-by-operating-activities

4707.2000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-780.38-857.2-951.6-870.8
-621.8
-536
-600.4
-374.7
-354.3
-330.6
-341.2
-354.9
-504.5
-409.8
-270
-192.9
-1203.2
-226.8
-135.8
-37.1
-84.6
-135.9
-172.7
-118.8
-170.6
-73.4

cash-flows.row.acquisitions-net

25.5631.1-11.8-120.6
-993.1
73.3
-140.2
-641.2
-1603.6
-1139
-218.8
-479.8
-1136.2
12.2
-7.8
172.9
-65.8
7.3
0.7
13.8
1.3
6.4
26.8
0
5.5
0

cash-flows.row.purchases-of-investments

-4195.27-3182-5675.9-5203.2
-5419.9
-3808.9
-4254.7
-2003
-2530.1
-2514
-2850
-1094.8
0
-5
-12
-79.6
-0.2
-3.6
-7.6
-0.9
-20.1
-150
-22.9
-26.5
-395.7
-467.6

cash-flows.row.sales-maturities-of-investments

2908.422228.64152.14394.8
6285.5
3765.5
4073.4
2420.9
3007.2
3125.6
2380.4
354.2
0
0.1
0.1
0.1
1.4
7.6
42.5
6.7
0.8
13
52.2
0
94.9
0

cash-flows.row.other-investing-activites

-284.8957.889.3
90
-5.4
31.1
46
256.6
68.1
110
26.1
98.9
17.5
221.9
6.5
4.8
-11.2
-25.1
18.8
31.4
-812.8
-262.4
-1081.5
-1116.7
-342.1

cash-flows.row.net-cash-used-for-investing-activites

-2326.47-821.7-2479.2-1790.5
-659.3
-511.4
-890.7
-552.1
-1224.2
-789.8
-919.6
-1549.1
-1541.9
-385
-67.8
-93
-1263
-226.7
-125.2
1.3
-71.2
-1079.2
-379
-1226.8
-1582.6
-883.1

cash-flows.row.debt-repayment

-1446.58-1741.8-462.2-28.5
-1251.8
-535.2
-530.2
-92.3
-0.7
-32.6
-23
-116.3
-139.9
-158.9
-13.1
-57.5
-57.3
-216.1
-1475
-1741.8
-2424
-3137.6
-3492.2
-3446.7
-1025.2
-205.7

cash-flows.row.common-stock-issued

0.28000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

-0.28000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-1076.37-988.3-855.8-491.8
-424.4
-384.8
-491.3
-181.6
-170
-423
-290
-276.6
-256.3
-304.6
-295.5
-201.8
-11.7
-14.6
-117.3
-132
-201
-266.2
-223.4
-211
-99.3
-37.2

cash-flows.row.other-financing-activites

3351.223180.1742.5-132.8
207.6
27.8
588.8
65.4
-53.5
-186.9
-0.9
500.3
74.2
118
51.8
46
90.3
76.5
1470.6
1935.7
2402.5
4551.5
3499.3
4307.2
2326.7
1752.5

cash-flows.row.net-cash-used-provided-by-financing-activities

-97.65450-575.5-653.1
-1468.6
-892.2
-432.6
-208.6
-224.2
-642.5
-313.9
107.3
-321.9
-345.4
-256.8
-213.3
21.3
-154.3
-121.8
62
-222.5
1147.8
-216.3
649.5
1202.2
1509.6

cash-flows.row.effect-of-forex-changes-on-cash

4.9456.3-2.3
-5.1
1
-0.3
-3.8
2
1.4
-0.2
-1.5
-0.1
-1
-2.3
0
-0.7
-0.4
-0.5
-0.1
0
0
0
0
-0.2
0

cash-flows.row.net-change-in-cash

2101.653203.7-41.9-575.4
90.9
569.3
587.5
796
-54.3
-171.1
-49.4
24.2
-652.1
223.5
521.4
548.7
-126
224
178
-193.7
-1013.2
96.7
-99.2
-423.8
-113.8
747.1

cash-flows.row.cash-at-end-of-period

25499.516353.52361.42403.2
2978.7
2842.1
2272.8
1685.3
889.3
943.6
1114.7
1343.5
1310.2
1962.3
1687.1
1165.7
616.7
694.9
489.1
674.9
304.4
276.1
179.5
278.7
709.6
1168.5

cash-flows.row.cash-at-beginning-of-period

23397.853149.72403.42978.7
2887.7
2272.8
1685.3
889.3
943.6
1114.7
1164.1
1319.2
1962.3
1738.8
1165.7
617
742.7
470.9
311.1
868.7
1317.6
179.5
278.7
702.5
823.4
421.4

cash-flows.row.operating-cash-flow

4707.24220.43006.41870.5
2224
1971.8
1911.2
1560.4
1392.1
1259.8
1184.4
1467.4
1211.8
954.9
848.3
855.1
1116.4
605.3
425.5
22.8
-719.6
28.1
496.1
153.4
266.9
120.6

cash-flows.row.capital-expenditure

-780.38-857.2-951.6-870.8
-621.8
-536
-600.4
-374.7
-354.3
-330.6
-341.2
-354.9
-504.5
-409.8
-270
-192.9
-1203.2
-226.8
-135.8
-37.1
-84.6
-135.9
-172.7
-118.8
-170.6
-73.4

cash-flows.row.free-cash-flow

3926.823363.22054.8999.7
1602.2
1435.9
1310.9
1185.7
1037.8
929.2
843.2
1112.5
707.3
545.1
578.3
662.1
-86.8
378.5
289.7
-14.3
-804.2
-107.8
323.4
34.6
96.3
47.2

利润表行

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 的收入与上期相比变化了 0.353%。据报告, 000999.SZ 的毛利润为 12604.36。该公司的营业费用为 9080.31,与上年相比变化了 35.183%. 折旧和摊销费用为 853.71,与上一会计期间相比变化了 0.213%. 营业费用报告为 9080.31,显示35.183% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0,同比增长0.196%. 营业收入为 3524.05,与上年相比变化了0.196%. 净利润的变化率为 0.165%。去年的净收入为2852.93.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997

income-statement-row.row.total-revenue

25524.282446418079.515320
13637.3
14701.9
13427.7
11119.9
8981.7
7900.2
7276.6
7801.6
6891.1
5525.2
4365.2
4852.7
4316.2
3397.8
2867.9
2969.5
2461.7
2674.5
2165.7
1867.3
1828.1
1476.4
1425.9
1109.8

income-statement-row.row.cost-of-revenue

12125.7411859.78313.16170.8
5119.6
4830.1
4160.4
3907.7
3362.3
3067
2812.2
3089.9
2678.2
2267.4
1686.2
2396.1
2352.9
1780.9
1551.4
1559.2
1363.5
1353.9
1103.3
917
1005.3
635.4
604.7
487.2

income-statement-row.row.gross-profit

13398.5512604.49766.39149.2
8517.6
9871.8
9267.4
7212.2
5619.5
4833.2
4464.4
4711.7
4212.9
3257.8
2678.9
2456.7
1963.3
1617
1316.5
1410.2
1098.2
1320.6
1062.4
950.3
822.8
841
821.2
622.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

700.37---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

380.93---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

7123.52---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-161.15-108.2792.5662.2
625.1
678.3
15.4
7.8
175.5
91.9
39.1
25.7
75.4
28.1
74.2
22.2
16.5
59.7
-13.1
8.5
-9.8
4.5
9.2
47.4
59.3
52.2
46.4
45.9

income-statement-row.row.operating-expenses

9498.499080.367176497.6
6337
7907.7
7550.3
5661.1
4291.2
3555.8
3243.7
3291.2
2950.2
2325.7
1759.1
1553.9
1309.5
1051.6
894.4
1036.5
1380.6
909.9
764.4
797.3
616.1
605.2
649.5
474.9

income-statement-row.row.cost-and-expenses

21624.232094015030.212668.4
11456.7
12737.8
11710.7
9568.8
7653.4
6622.9
6055.8
6381.1
5628.4
4593.1
3445.4
3949.9
3662.4
2832.4
2445.9
2595.8
2744.1
2263.8
1867.7
1714.3
1621.3
1240.7
1254.2
962.1

income-statement-row.row.interest-income

76.05106.973.567
73.7
22.8
31.6
10
12.3
21.9
24.4
29.9
24.2
27.4
18.4
13.1
10.6
18.2
12
44.6
61
65.3
66.5
141.7
78.8
0
0
0

income-statement-row.row.interest-expense

91.8980.821.213.3
5.1
4.4
25.8
28
28.2
27.9
27.6
22.6
8.8
10.5
1.8
9.6
14.4
120.8
198.8
204.7
203.5
189.8
172.3
157.6
102.8
25.1
29.4
21.6

income-statement-row.row.selling-and-marketing-expenses

7123.52---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

192.28225.216.2-28.4
-10.8
39.2
1.8
-32.8
124.9
251.7
38.9
12.5
20.1
15.9
114.2
1.7
-7.8
-181
-249.7
-226.4
-417.1
-149.2
-114.5
13.4
34.5
23.6
17.3
-4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-161.15-108.2792.5662.2
625.1
678.3
15.4
7.8
175.5
91.9
39.1
25.7
75.4
28.1
74.2
22.2
16.5
59.7
-13.1
8.5
-9.8
4.5
9.2
47.4
59.3
52.2
46.4
45.9

income-statement-row.row.total-operating-expenses

192.28225.216.2-28.4
-10.8
39.2
1.8
-32.8
124.9
251.7
38.9
12.5
20.1
15.9
114.2
1.7
-7.8
-181
-249.7
-226.4
-417.1
-149.2
-114.5
13.4
34.5
23.6
17.3
-4

income-statement-row.row.interest-expense

91.8980.821.213.3
5.1
4.4
25.8
28
28.2
27.9
27.6
22.6
8.8
10.5
1.8
9.6
14.4
120.8
198.8
204.7
203.5
189.8
172.3
157.6
102.8
25.1
29.4
21.6

income-statement-row.row.depreciation-and-amortization

510.85853.7704729.5
642.6
630.8
349.4
320.4
282.5
233.7
234.8
231.8
224.7
133.6
117.4
105.5
83.1
69
83.6
72.7
90.4
64.2
63.6
52.7
71.6
56.5
27.8
78.2

income-statement-row.row.ebitda-caps

4353.5---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

3856.8435242947.22457.4
2070.2
2529.4
1703.5
1510.5
1293.7
1442.6
1228
1411.8
1262.1
926.8
962.6
885
635
325.6
258.1
193.3
-649.8
279.8
185.7
126.7
196.2
208.3
143.2
98.5

income-statement-row.row.income-before-tax

4049.123749.22963.42429.1
2059.4
2568.6
1718.9
1518.3
1453.2
1529
1259.6
1433
1282.8
948.1
1034
904.5
646
384.4
208.7
174.5
-679.5
272.9
189.2
170.3
248.4
259.9
189.3
144.1

income-statement-row.row.income-tax-expense

650.56581466.4348.2
441.9
429.5
244
191.8
245.4
254.3
187.5
218.3
201.7
133
174.9
142.9
104.9
100.3
42.1
59.9
39.3
49.8
35.8
46.1
42.7
29.5
30.2
28.6

income-statement-row.row.net-income

3065.732852.92448.82055.1
1597.5
2112.5
1432.1
1301.7
1197.8
1249.2
1035.9
1181.1
1014.1
760.4
816
709.5
500.1
279.8
164.9
119.9
-720.8
208.8
165
121
201.6
220.2
150.8
98.8

常见问题

什么是 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) 总资产是多少?

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) 总资产为 40148455933.000.

什么是企业年收入?

年收入为 13268686742.000.

企业利润率是多少?

公司利润率为 0.525.

什么是公司自由现金流?

自由现金流为 4.011.

什么是企业净利润率?

净利润率为 0.120.

企业总收入是多少?

总收入为 0.151.

什么是 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) 净利润?{{符号}}净利润(净收入)是多少?

净利润(净收入)为 2852931664.000.

公司总债务是多少?

债务总额为 3942294961.000.

营业费用是多少?

运营支出为 9080313650.000.

公司现金是多少?

企业现金为 7026231386.000.